Randox Introduces PSA Test for Indications of Prostate Cancer
Levels of PSA are low in healthy men but elevate in the presence of prostate cancer and other mentioned conditions.
Read MorePosted by Chris Wolski | May 18, 2023 | Prostate |
Levels of PSA are low in healthy men but elevate in the presence of prostate cancer and other mentioned conditions.
Read MorePosted by Melanie Hamilton-Basich | Apr 26, 2023 | Prostate |
A new minimally invasive prostate biopsy procedure reduces the risk of infection, improves imaging for accuracy, and may increase cancer detection in a clinic setting.
Read MorePosted by Melanie Hamilton-Basich | Apr 25, 2023 | Prostate |
The American Urological Association and Society of Urologic Oncology have released the 2023 clinical practice guideline on the early detection of prostate cancer.
Read MorePosted by Andy Lundin | Apr 4, 2023 | Amplification Technologies, Prostate |
A new study informed use of PARP inhibitors beyond BRCA1/2-deficient tumors and reevaluated biomarkers for PARP inhibition in prostate cancer.
Read MorePosted by Andy Lundin | Mar 30, 2023 | Prostate |
A rapid test for advanced prostate cancer can quickly identify people with “actionable” gene variants eligible for new targeted therapies.
Read More